WA People
BILL · 2005–06 SESSION · LATEST VERSION SSB 6844

SB 6844: Biotech/biomedical business

Evaluating the business climate in areas with successful biotechnology and medical device manufacturing businesses.

Summary

  • The Joint Legislative Audit and Review Committee is directed to review the top biotechnology and medical device manufacturing centers in the nation, as listed in this act, and identify the best practices in economic development and public policy to encourage the formation and maturation of these sectors in Washington. A report must be delivered to the appropriate committees of the Legislature by December 15, 2006.

From the Senate Bill Report (SB 6844), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 26, 2006
  2. Out of committeestopped here
  3. Passed Senate
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Paull Shin (D-21)
Introduced
January 26, 2006 in the Senate
Last action
February 2, 2006
Companion bill
HB 3119
Budget
Has a fiscal note
Versions
SB 6844, SSB 6844

AN ACT Relating to a study of successful United States biotechnology and biomedical device business clusters by the joint legislative audit and review committee;

Sponsors

Prime sponsor: Paull Shin (D-21)

1 co-sponsor (1 Democrat, 0 Republicans)

Jean Berkey D-38

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. ITED - Majority; 1st substitute bill be substituted, do pass. (SSB 6844)
  2. And refer to Ways & Means. (SSB 6844)
  3. Referred to Ways & Means. (SSB 6844)
  4. Referred to Ways & Means.
  5. And refer to Ways & Means.
  6. ITED - Majority; 1st substitute bill be substituted, do pass.
  7. First reading, referred to International Trade & Economic Development.

SB 6844 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page